3.0.0 8139 2023-01-11T13:45:03Z 2023-01-11T13:45:03Z House HR 2020-09-01 116 [Congressional Record Volume 166, Number 152 (Tuesday, September 1, 2020)][House]From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]By Mr. BILIRAKIS:H.R. 8139.Congress has the power to enact this legislation pursuantto the following:This bill is enacted pursuant to Article 1, Section 8,Clause 18 of the Constitution of the United States.[Page H4318]]]> hsif00 Energy and Commerce Committee House Standing Referred to 2020-09-01T16:32:15Z 2020-09-01 Referred to the House Committee on Energy and Commerce. IntroReferral H11100 2 House floor actions hsif00 Energy and Commerce Committee 2020-09-01 Introduced in House IntroReferral Intro-H 9 Library of Congress 2020-09-01 Introduced in House IntroReferral 1000 9 Library of Congress B001257 Rep. Bilirakis, Gus M. [R-FL-12] Gus Bilirakis R FL M. 12 N S001200 Rep. Soto, Darren [D-FL-9] Darren Soto D FL 9 2020-09-01 True Health Cardiovascular and respiratory health Emergency medical services and trauma care Home and outpatient care Infectious and parasitic diseases Inflation and prices Medicaid Prescription drugs Health 00 2020-09-01 Introduced in House 2020-11-10T17:12:27Z Surplus Utilization of Pharmaceutical Products Leveraged In Emergency Scenarios Act of 2020 or the SUPPLIES Act of 2020

This bill excludes certain short-dated drugs from rebate calculations under the Medicaid Drug Rebate Program during the public health emergency relating to COVID-19 (i.e., coronavirus disease 2019). Specifically, the bill excludes from such calculations direct sales of drugs that (1) have a shelf life of one year or more and expire one year after the date of sale, or (2) have a shelf life of less than one year and expire after the same number of days as the shelf life following the date of sale.

]]> SUPPLIES Act of 2020 Display Title SUPPLIES Act of 2020 Short Title(s) as Introduced SUPPLIES Act of 2020 Introduced in House IH Short Title(s) as Introduced Surplus Utilization of Pharmaceutical Products Leveraged In Emergency Scenarios Act of 2020 Introduced in House IH Official Title as Introduced To amend title XIX of the Social Security Act to remove direct sales of drugs near expiration during the COVID-19 emergency from the calculation of certain pricing metrics under the Medicaid program. Introduced in House IH Introduced in House 2020-09-01T04:00:00Z https://www.govinfo.gov/content/pkg/BILLS-116hr8139ih/xml/BILLS-116hr8139ih.xml 2020-09-01 Referred to the House Committee on Energy and Commerce. text/xml EN Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain. Congressional Research Service, Library of Congress This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.